Alkem Laboratories Limited
Climate Impact & Sustainability Data (2016-17, 2022-23, 2023-24)
Reporting Period: 2016-17
Environmental Metrics
Waste Generated:Waste water effluent (KL): 92,640.9; ETP Sludge (MT): 43.77; Process Waste (MT): 699.13
ESG Focus Areas
- Community Investment
- Employee Well-being
- Quality and Compliance
Environmental Achievements
- Installation of energy-efficient equipment (LED lights, VFDs, economizers) resulting in energy savings.
- Replacement of boiler fuel with briquettes, reducing energy consumption.
- Use of solar energy at Mandva API plant.
Social Achievements
- Launched various employee engagement initiatives (Star Awards, Service Awards, Applaud Awards).
- Provided 30,000+ person days of training in FY17.
- Undertook various CSR initiatives (healthcare, education, vocational training, environment conservation).
Governance Achievements
- Successful US FDA inspections at Daman, Baddi, and Ankleshwar facilities.
- Implementation of a Whistle Blower Policy.
- Establishment of an Internal Complaints Committee to address sexual harassment complaints.
Climate Goals & Targets
Environmental Challenges
- Expansion of NLEM list leading to price cuts in India.
- Temporary hardships due to demonetization.
- Pricing pressure in the US market due to buyer consolidation.
- Regulatory compliance risks, exchange rate volatility, and geopolitical risks for exports.
Mitigation Strategies
- Outperformance of the market through volume growth, new product launches, and improved field force productivity.
- Cost optimization measures and improved operating efficiencies.
- Focus on key international markets and differentiated products.
- Continued investment in R&D and accelerated ANDA filings.
Supply Chain Management
Responsible Procurement
- Green procurement initiatives focusing on raw materials, packaging, and finished goods.
- Use of organic/bio fuels (80% of inputs for utility).
Climate-Related Risks & Opportunities
Awards & Recognition
- EY Entrepreneur of the Year Award (Samprada Singh and Basudeo N. Singh)
- Emerging Pharma Leader of 2016 (Sandeep Singh)
- CEO of the Year 2016 (Prabhat Agrawal)
- Brand of the Year (Pan)
- HR Tech Award for Best use of Technology in Human Resources
- Emerging Dermatology Brand 2015 (Melbild)
- Silver Award, New Introduction of the Year, Chronic Category (Melbild)
- Brand of the Year (Clavam)
Reporting Period: 2022-23
Environmental Metrics
Renewable Energy Share:16.75%
ESG Focus Areas
- Healthcare
- Education
- Environment
- Sports
- Rural Development
Environmental Achievements
- Planted over 1 million trees
- Installed solar street lights
- Developed a door-to-door garbage collection system
- 90.49% wastewater reused
- 25.80% hazardous waste disposed of sustainably
- 16.75% energy from renewable sources
Social Achievements
- Impacted over 10 lakh lives across India
- Positively impacted 3 lakh lives through early cancer detection, anaemia-free panchayats, and supporting surgeries
- Provided scholarships and developed infrastructure for education
- Supported sports personalities with ₹10 Million for training
- Empowered rural women and youth through Project Saksham, Project Swavalamban, and Alkem Aatma Nirbhar Gram
- Supported cochlear implants, spine surgeries, and cataract surgeries
Governance Achievements
- 25% women’s representation on the board
- Established a robust monitoring and evaluation mechanism for CSR programs
Climate Goals & Targets
Environmental Challenges
- Limited accessibility and affordability of healthcare in India
- High TB burden in India, particularly in Sikkim
- High rate of anaemia among women and children
- Limited infrastructure and recognition for lesser-known sports
Mitigation Strategies
- Partnered with Tata Memorial Centre (TMC) to provide cancer care
- Established mini cancer units and a home-based palliative care unit
- Launched Alkem Anaemia Mukti Abhiyaan (AAMA)
- Supported training programs for emerging sports talents
- Developed health centers and mobile health units to improve healthcare access
Supply Chain Management
Climate-Related Risks & Opportunities
Awards & Recognition
- 9th National CSR Times Award
- CSR Excellence Award by Economic Times (India Pharma World Awards 2023)
- CSR Excellence Award by Global Business School, Amity Pune
Reporting Period: 2023-24
Environmental Metrics
Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:683,686 KL
Waste Generated:4,189.0 MT
Carbon Intensity:Not disclosed
ESG Focus Areas
- Environment, Health, and Safety (EHS)
- Climate Change
- GHG Emissions
- Biodiversity
- Energy Management
- Waste Management
- Water Management
- Product Quality
- Occupational Health & Safety
- Human Resource Development
- Sustainable Supply Chain
- Human Rights
- Community Engagement
- R&D and Innovation
- Data Privacy and cybersecurity
- Clinical Trial Conduct
- Pharmacovigilance
- Environmental Compliance
- Corporate Governance
- Business Continuity
- Resilient Business Performance
- Sales and marketing practices
- Combatting counterfeit medicines
Environmental Achievements
- 10.2% reduction in total volume of water consumption
- 11.5% reduction of total electricity consumption (from non-renewable source - Grid)
- 4,189.0 MT Waste recycled
- 53.48% NOx reduction
- 32.94% SOx reduction
Social Achievements
- Certified as a “Great Place to Work” for the fourth time
- Featured in India’s Top 100 best companies to work for
- Launched ‘Alkemites Assistance Program’ for employee well-being
- Enhanced term life insurance coverage for employees
- Launched impactful signature training programs
- 11 lakh Lives benefited through CSR initiatives
Governance Achievements
- Appointment of Dr. Vikas Gupta as Chief Executive Officer
- Appointment of Mr. Nitin Agrawal as Chief Financial Officer
- Creation of the Chief Executive Officer position
- Strengthened leadership team
Climate Goals & Targets
Long-term Goals:
- Not disclosed
Medium-term Goals:
- Achieve water neutrality by FY 2029-30
- Reduce Scope-1 and Scope-2 GHG emissions by 42% by FY’33
Short-term Goals:
- Reduce water consumption by 10% by FY 2029-30
- Reduce Scope 1 & 2 GHG emissions by 42% by FY 2032-33
- Achieve zero waste to landfill at operating sites by FY 2025-26
- Increase overall gender diversity to 5% by FY 2026-27
- More than 75% sites certified with ISO 45001 by FY’26
- Obtain ISO 27001 certification by FY’26
Environmental Challenges
- Supply chain challenges in the US
- Subdued growth in certain acute therapies in India
- Stiff competition from multiple competitors
- Inadequate control on internal processes impacting product quality
- Adverse pricing regulations affecting essential products
- Disruption in production or supply chain at Sikkim Facility
- Non-compliance with regulatory requirements
- Changes in science and technology impacting R&D costs
- Redundancy in technology used, lack of proper technological support or lack of awareness of information security among employees
- Lack of energy efficiency consciousness
- Lack of water resources at key locations
- Violation of human rights principles
- Gaps in pharmaceutical supply chain
- Non-compliances with environmental regulations
- Unethical behaviour or corporate misconduct
- Poor corporate governance practices
- Disruption to normal business operations
- Presence of counterfeit products in the market
Mitigation Strategies
- Cost optimization initiatives
- Investing in R&D to develop unique products
- Strong adherence to CGMP guidelines
- Investing significantly in R&D to develop molecules/drugs ahead of competition
- Robust cost control measures
- Setting up alternative in-house manufacturing facilities and using contract manufacturing
- Compliance and integrity measures
- Astute business planning
- Regular VAPT and IT audits
- Implementing Microsoft Active Directory
- Specialized pharmaceutical courses
- Multiple initiatives for energy management
- Monitoring and reducing water consumption
- Rainwater harvesting and effluent treatment plants
- Well-structured Human Rights policy
- Code of Ethics for stakeholders
- Comprehensive business continuity measures
- Integrating ESG risks into Enterprise Risk Management system
- Anti-counterfeiting Security features
Supply Chain Management
Supplier Audits: 90% of new suppliers screened on ESG criteria by FY’25
Responsible Procurement
- Code of Ethics for suppliers, vendors, and contractors
- ESG screening criteria for new suppliers
- Associate Membership with Pharmaceutical Supply Chain Initiative (PSCI)
Climate-Related Risks & Opportunities
Physical Risks
- Adverse weather events causing business disruptions
Transition Risks
- Regulatory changes impacting essential products
Opportunities
- Increased demand for healthcare services due to climate change impacts
Reporting Standards
Frameworks Used: Null
Certifications: ISO 14001, ISO 45001, ISO 50001
Third-party Assurance: DNV Business Assurance India Pvt. Ltd.
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Great Place to Work
- India’s Best Companies to Work For - Top 100
- EY Entrepreneur of the Year in Life Sciences
- Hurun India Lifetime Achievement Award
- APEX India Foundation CSR Excellence Award 2023